News Releases
Recent and archived press releases with clinical and research news
-
January 21, 2026
Experts warn parents about carbon monoxide risks as freezing temps persist: signs, causes
As residents prepare for frigid temperatures, injury and prevention experts at Monroe Carell Jr. Children’s Hospital at Vanderbilt urge parents to be aware of potential dangers. -
January 20, 2026
Bayer and Vanderbilt University Medical Center to advance treatments for cardiovascular and kidney diseases
The collaboration will leverage VUMC’s resource platform, including its comprehensive datasets hosted in Vanderbilt’s BioVU collection of DNA and plasma to enable data-driven insights and to accelerate discovery and development. -
January 16, 2026
Dolly Parton honors milestone birthday by giving back to Monroe Carell Jr. Children’s Hospital at Vanderbilt
Proceeds from release of new rendition of “Light of a Clear Blue Morning” to benefit Monroe Carell. -
January 16, 2026
Study finds so-called super agers tend to have at least two key genetic advantages
Super agers were 68% less likely to harbor the gene nobody wants,APOE-ε4, compared to individuals with AD dementia in the same 80+ age group. -
January 15, 2026
Immunometabolism may be a key to controlling sepsis: study
This discovery may lead to new ways to block metabolic changes contributing to excessive and ineffective inflammation, reset the immune system, and bring sepsis under control. -
January 14, 2026
Vanderbilt Transplant Center nation’s largest after performing record number of solid organ transplants in 2025
Through dramatic growth, the VTC is now the largest transplant center in the country by volume, according to data from the United Network for Organ Sharing. -
January 9, 2026
Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study
The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023.